Clinical Trials Directory

Trials / Completed

CompletedNCT00576849

A Total Balanced Volume Replacement Regimen in Elderly Cardiac Surgery Patients

Phase 4 Study of a Total Balanced Volume Replacement Regimen in Elderly Cardiac Surgery Patients

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Klinikum Ludwigshafen · Academic / Other
Sex
All
Age
80 Years
Healthy volunteers
Not accepted

Summary

A total balanced fluid replacement strategy is a promising concept for correcting hypovolemia. The effects of a balanced fluid management including a new balanced hydroxyethylstarch (HES) in elderly cardiac surgery patients will be studied.

Conditions

Interventions

TypeNameDescription
DRUGBalanced HES 130/0.42Volume is administered perioperatively and during the first 48 hrs after surgery when mean arterial pressure (MAP) was \<60mmHg and pulmonary capillary wedge pressure (PCWP) or central venous pressure (CVP) is \<10 mmHg
DRUGBalanced HES 130/0.42Volume will be administered perioperatively and during the first 48 hrs after surgery when mean arterial pressure (MAP) is \<60mmHg and pulmonary capillary wedge pressure (PCWP) or central venous pressure (CVP) is \<10 mmHg
DRUG6% HES 130/0.4 prepared in saline solutionVolume will be administered perioperatively and during the first 48 hrs after surgery when mean arterial pressure (MAP) is \<60mmHg and pulmonary capillary wedge pressure (PCWP) or central venous pressure (CVP) is \<10 mmHg

Timeline

Start date
2007-12-01
Primary completion
2010-05-01
Completion
2010-05-01
First posted
2007-12-19
Last updated
2010-05-27

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00576849. Inclusion in this directory is not an endorsement.